Olema Pharmaceuticals annual total assets
2020
2021
2022
2023
2024
2025
Olema Pharmaceuticals Total Assets Growth & History (OLMA)
Olema Pharmaceuticals's total assets was $533.4M for fiscal 2025.
View full Olema Pharmaceuticals company overviewOlema Pharmaceuticals annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $533.4M | $82.5M | +18.28% |
| 2024 | 2024-12-31 | $451.0M | $174.0M | +62.84% |
| 2023 | 2023-12-31 | $276.9M | $61.3M | +28.43% |
| 2022 | 2022-12-31 | $215.6M | −$80.3M | −27.13% |
| 2021 | 2021-12-31 | $295.9M | −$46.8M | −13.65% |
| 2020 | 2020-12-31 | $342.7M | — | — |
Olema Pharmaceuticals quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $486.6M | $104.6M | +27.38% |
| Q1 2026 | 2026-03-31 | $530.6M | $121.0M | +29.54% |
| Q4 2025 | 2025-12-31 | $533.4M | $82.5M | +18.28% |
| Q3 2025 | 2025-09-30 | $352.5M | $122.3M | +53.13% |
| Q2 2025 | 2025-06-30 | $382.0M | $127.4M | +50.07% |
| Q1 2025 | 2025-03-31 | $409.6M | $145.9M | +55.35% |
| Q4 2024 | 2024-12-31 | $451.0M | $174.0M | +62.84% |
| Q3 2024 | 2024-09-30 | $230.2M | −$62.6M | −21.39% |
| Q2 2024 | 2024-06-30 | $254.6M | $76.9M | +43.31% |
| Q1 2024 | 2024-03-31 | $263.7M | $67.9M | +34.70% |
| Q4 2023 | 2023-12-31 | $276.9M | $61.3M | +28.43% |
| Q3 2023 | 2023-09-30 | $292.8M | $60.8M | +26.21% |
| Q2 2023 | 2023-06-30 | $177.6M | −$73.0M | −29.12% |
| Q1 2023 | 2023-03-31 | $195.8M | −$81.7M | −29.43% |
| Q4 2022 | 2022-12-31 | $215.6M | −$80.3M | −27.13% |
| Q3 2022 | 2022-09-30 | $232.0M | −$77.8M | −25.11% |
| Q2 2022 | 2022-06-30 | $250.6M | −$71.6M | −22.23% |
| Q1 2022 | 2022-03-31 | $277.4M | −$53.9M | −16.26% |
| Q4 2021 | 2021-12-31 | $295.9M | −$46.8M | −13.65% |
| Q3 2021 | 2021-09-30 | $309.8M | — | — |
| Q2 2021 | 2021-06-30 | $322.2M | — | — |
| Q1 2021 | 2021-03-31 | $331.3M | — | — |
| Q4 2020 | 2020-12-31 | $342.7M | — | — |
Olema Pharmaceuticals total assets trends
Over the last five fiscal years, Olema Pharmaceuticals's total assets increased from $342.7M to $533.4M, a change of $190.7M. The latest reported quarter, Q2 2026, shows $486.6M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Olema Pharmaceuticals source filings ↗